Insulet's SECURE-T2D Pivotal Trial Results Demonstrate Omnipod® 5 Improves Clinical Outcomes and Quality of Life in Type 2 DiabetesBusiness Wire • 06/21/24
Insulet Announces Full Commercial Launch of Omnipod 5 with Expanded Sensor Integrations in the United Kingdom and the NetherlandsBusiness Wire • 06/20/24
Follow the Whales: 3 Genius Stocks the Smart Money Is Piling Into for Triple-Digit GainsInvestorPlace • 05/19/24
Insulet's 2023 Sustainability Report Highlights Commitment to Product Accessibility and Responsible GrowthBusiness Wire • 05/07/24
Gear Up for Insulet (PODD) Q1 Earnings: Wall Street Estimates for Key MetricsZacks Investment Research • 05/06/24